Medifast, Inc. (MED) Capital expenditures 2016–2025
Medifast, Inc. (MED) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5.6MFY2025 · since FY2016: $2.9M → $5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.6M | -24.7% |
| FY2024 | $7.5M | +15.0% |
| FY2023 | $6.5M | -61.1% |
| FY2022 | $16.7M | -51.2% |
| FY2021 | $34.2M | +481.1% |
| FY2020 | $5.9M | -41.5% |
| FY2019 | $10.1M | +103.6% |
| FY2018 | $4.9M | +52.4% |
| FY2017 | $3.2M | +12.7% |
| FY2016 | $2.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice